0001104659-15-065272.txt : 20150915
0001104659-15-065272.hdr.sgml : 20150915
20150915163052
ACCESSION NUMBER: 0001104659-15-065272
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150911
FILED AS OF DATE: 20150915
DATE AS OF CHANGE: 20150915
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nivalis Therapeutics, Inc.
CENTRAL INDEX KEY: 0001626199
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208969493
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-945-7700
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: N30 Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20141121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Congleton Jon
CENTRAL INDEX KEY: 0001644975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37449
FILM NUMBER: 151108023
MAIL ADDRESS:
STREET 1: 3122 STERLING CIRCLE, SUITE 200
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
a4.xml
4
X0306
4
2015-09-11
0
0001626199
Nivalis Therapeutics, Inc.
NVLS
0001644975
Congleton Jon
C/O NIVALIS THERAPEUTICS, INC.
3122 STERLING CIRCLE, SUITE 200
BOULDER
CO
80301
1
1
0
0
President and CEO
Stock Option (Right to Buy)
15.28
2015-09-11
4
A
0
121100
0
A
2025-09-11
Common Stock
121100
121100
D
The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
The options vest and become exercisable over a four-year period, with 25% vesting on the first anniversary of the grant date (September 11, 2016) and 1/48th of the options vesting monthly thereafter.
/s/ R. Michael Carruthers, Attorney-in-Fact
2015-09-15